American Healthcare REIT price target raised to $40 from $35 at Citizens JMP

Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $40 from $35 and keeps an Outperform rating on the shares. American Healthare REIT’s Q1 core FFO beat consensus expectations, with the beat coming from the “outstanding” results from the Trilogy portfolio, the analyst tells investors in a research note. American Healthcare REIT is uniquely positioned to outperform over the foreseeable future given its exposure to REIT Investment Diversification and Empowerment Act assets, which carry some of the best fundamentals across any real estate asset class, the firm says.